Premium accounts now available! Sign up and create a premium account. Read more Close

Advertisement

Image

Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis

Journal content Created on 02 Jul 2026 The New England Journal of Medicine

Advertisement

Stats

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 12
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement